BotVax B by Neogen is a USDA-approved monovalent vaccine for the prevention of equine botulism caused by Clostridium botulinum Type B in healthy horses. USDA APHIS lists BotVax B under the licensed biological product name Clostridium Botulinum Type B Toxoid for equine use.
The vaccine may be administered to healthy adult horses, pregnant mares, and foals beginning at 2 weeks of age. It is designed to provide protection against the major forms of Type B equine botulism, including forage poisoning, toxicoinfectious botulism in foals, commonly called Shaker Foal Syndrome, and wound botulism.
BotVax B is specific to Type B botulism and does not provide protection against other C. botulinum toxin types.
BotVax B contains purified botulinum Type B toxoid adsorbed onto aluminum phosphate. Vaccination stimulates the horse's immune system to develop an immune response against botulinum Type B toxin.
The initial three-dose series establishes immunity, followed by annual booster vaccination to maintain protection.
Research cited by the manufacturer indicates that pregnant mares vaccinated during the third trimester, with the third dose or booster administered 2–4 weeks before foaling, develop antibodies that become concentrated in colostrum. These antibodies can provide passive antibody protection to normal suckling foals that receive adequate colostrum.
For the prevention of equine botulism caused by Clostridium botulinum Type B in healthy horses.
This product does not provide protection against other Clostridium botulinum toxin types.
Active Ingredients:
Inactive Ingredients:
Shake well before use.
Administer using aseptic technique.
Inject 2 mL intramuscularly at monthly intervals for a total of 3 doses.
Following completion of the initial series, administer a single 2 mL intramuscular booster annually.
Weight / Dosage
Healthy Horses:
Pregnant Mares:
The manufacturer reports that pregnant mares immunized during the third trimester, with the third dose or booster administered 2–4 weeks before foaling, develop antibodies that are concentrated in colostrum and can provide passive antibodies to normal suckling foals.
Foals:
May be administered to healthy foals 2 weeks of age and older.
Reported reactions may include:
Contact a veterinarian promptly if a serious or unexpected reaction occurs following vaccination.
Store unopened vials refrigerated at 2°–8°C (35°–45°F). Do not freeze. Use the entire contents of the container when first opened. Do not store opened vials.
Heartland ships vaccines in cooling packaging and currently requires overnight delivery for vaccines.
Disposal
Dispose of used needles immediately in an approved sharps container. Dispose of empty vaccine containers and unused or expired vaccine according to applicable federal, state, and local requirements.